《Table 1Details of the MP strategy.》

  提示：宽带有限、当前游客访问压缩模式

本系列图表出处文件名：随高清版一同展现

《Machine perfusion for liver transplantation: A concise review of clinical trials》

1. 获取 高清版本忘记账户？点击这里登录

1. 下载图表忘记账户？点击这里登录

MP:machine perfusion；HMP:hypothermic machine perfusion；HOPE:hypothermic oxygenation machine perfusion；EHOPE:end ischemia HOPE；DHOPE:dual HOPE；SMP:subnormothermic machine perfusion；COR:controlled oxygenated rewarming；NMP:normothermic machine perfusion；PV:p

In addition，the HOPE-DBD multicenter trial（NCT01317342，main end-points:postoperative peak ALT，hospital and ICU stay，patient and graft survival），DHOPE-DCD multicenter trial（NCT02584283，main end-points:biliary complications，patient and graft survival，hospital and ICU stay，PNF）and HOPE-ECD multicenter trial（NCT03124641，main end-points:postoperative peakALT，postoperative complications，hospital and ICU stay，patient and graft survival）are ongoing.These trials are expected to provide more details on the potential advantages of HMP and liver viability assessment.The details of HMP are summarized in Table 2.